Aerosol Delivery and COPD Readmissions

Par un écrivain mystérieux

Last updated 19 juin 2024

Full article: TRONARTO: A Randomized, Placebo-Controlled Study of Tiotropium/Olodaterol Delivered via Soft Mist Inhaler in COPD Patients Stratified by Peak Inspiratory Flow

Device Selection and Outcomes of Aerosol Therapy

Aerosol Delivery & COPD Readmissions: Proper aerosol therapy adherence for COPD patients can help prevent and reduce 30-day readmissions rates for hospitals, but compliance can rely on finding the right technology

Readmission Risk in Chronic Obstructive Pulmonary Disease Patients: Comparative Study of Nebulized β2-Agonists

Device Selection and Outcomes of Aerosol Therapy

Chronic Obstructive Pulmonary Disease in Post-acute/Long-term Care Settings: Seizing Opportunities to Individualize Treatment and Device Selection - ScienceDirect

Face Mask Leak Determines Aerosol Delivery in Noninvasive Ventilation

Full article: Managing hospitalized patients with a COPD exacerbation: the role of hospitalists and the multidisciplinary team

Aerosol drug‐delivery and short‐term clinical outcomes of suboptimal peak inspiratory flow rate in chronic obstructive pulmonary disease - Harb - 2021 - International Journal of Clinical Practice - Wiley Online Library

Home Use - evidence

Recommandé pour vous

Tu pourrais aussi aimer